## **Core Concept**
BCG (Bacillus Calmette-Guérin) is a vaccine primarily used against tuberculosis. However, due to its ability to stimulate the immune system, it has applications in cancer immunotherapy, particularly for certain types of bladder cancer.

## **Why the Correct Answer is Right**
The correct answer, **Bladder Cancer**, is associated with the use of BCG in tumor therapy. BCG is instilled into the bladder to treat superficial bladder cancer and carcinoma in situ. It works by stimulating an immune response against cancer cells. The BCG vaccine is thought to induce a local immune response in the bladder, which helps to destroy cancer cells. This application takes advantage of the immune system's ability to target and eliminate malignant cells.

## **Why Each Wrong Option is Incorrect**
- **Option A: Breast Cancer** - BCG is not a standard treatment for breast cancer. While immunotherapy is being explored for various cancers, including breast cancer, BCG's role is specifically noted in bladder cancer.
- **Option B: Lung Cancer** - Similarly, BCG is not commonly used in the treatment of lung cancer. Lung cancer treatment typically involves surgery, chemotherapy, radiation, and targeted therapy.
- **Option C: Colorectal Cancer** - BCG has no established role in the treatment of colorectal cancer. Treatment for colorectal cancer usually involves surgery, chemotherapy, and targeted therapy.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that BCG is specifically used for **intravesical therapy** in bladder cancer, especially for **Carcinoma in Situ (CIS)** and **Ta/T1 papillary tumors**. This is a critical application of immunotherapy in oncology and is a high-yield fact for exams.

## **Correct Answer:** . **Bladder Cancer**